Cingulate Inc share price logo

Cingulate Inc Share Price

NASDAQ: CING

Small Cap

$5.88

-0.15

(-2.49%)

as on

Cingulate Inc Stock Performance

as on April 22, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $5.84
    $6.60
    downward going graph

    0.68%

    Downside

    12.24%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.20
    $11.89
    downward going graph

    45.58%

    Downside

    102.21%

    Upside

    downward going graph

Cingulate Inc share price movements today

Previous Close
$6.03
Open
$6.12
Volume
901.6K
Day's Low - High
$5.84 - $6.60
52 Week Low - High
$3.20 - $11.89

Cingulate Inc Historical Returns

1 Month Return
-20.6 %
3 Month Return
+ 9.12 %
1 Year Return
+ 40.87 %
3 Year Return
-97.65 %
5 Year Return
0 %

Cingulate Inc Stock Fundamentals & Key Indicators

Check Cingulate Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$73.9M

EPS (TTM)

-1.8775

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-19.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-450.60%

Cingulate Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cingulate Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$73.9MNANA0.00%
BUY$41.2B123.87%131.818.45%
BUY$111.1B102.14%28.532.94%
NA$36.5BNA128.255.37%
BUY$79.2B52.39%18.0531.41%

Stock Returns calculator for Cingulate Inc Stock including INR - Dollar returns

The Cingulate Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Cingulate Inc investment value today

Current value as on today

₹1,55,161

Returns

₹55,161

(+55.16%)

Returns from Cingulate Inc Stock

₹41,346 (+41.35%)

Dollar Impact

₹13,814 (+13.81%)

Analyst Recommendation on Cingulate Inc Stock

Based on 10 analysts

BUY

70.00%

Buy

30.00%

Hold

0.00%

Sell

Based on 10 analysts, 70% of analysts recommend a 'BUY' rating for Cingulate Inc. Average target price of $28.7

Cingulate Inc Share Price Target

Get share price movements and forecasts by analysts on Cingulate Inc.

What analysts predicted

79.51%UPSIDE

Target Price

$28.7

Current Price

$5.88

Analyzed by

10 Analysts

Target

$28.70

Cingulate Inc target price $28.7, a slight upside of 79.51% compared to current price of $5.88. According to 10 analysts rating.

Cingulate Inc Stock’s Investor Sentiment and Interest

Search interest for Cingulate Inc Stock has increased by 13% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:13% versus previous 30 day period

Cingulate Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-3,849
-
-
12,982
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-6
-5
-2
-3
-3
-6
-3
-4
-5
-5
EBITDA
-6
-5
-2
-3
-3
-5
-3
-4
-7
-3
Interest Expense
253
0
408
0
50
0
96
138
573
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-6
-5
-2
-3
-4
-6
-3
-4
-7
-6
Income Tax Expense
6,108
0
0
-
-
-
-
-
-
-
Net Income
-6
-5
-2
-3
-4
-6
-3
-4
-7
-6
Net Profit Margin
0.00%
0.00%
0.08%
0.00%
0.00%
-0.05%
0.00%
0.00%
0.00%
0.00%

Cingulate Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
Operating Income
-11
-7
-20
-17
-22
-15
-19
EBITDA
-11
-6
-19
-17
-22
-14
-19
Interest Expense
-
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
Income Before Tax
-11
-7
-20
-17
-23
-15
-22
Income Tax Expense
0
0
0
0
0
0
-
Net Income
-11
-7
-20
-17
-23
-15
-22
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cingulate Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-6
-2
-3
-3
-6
-3
-4
-7
19,975
Operating Cash Flow
-
-8
-1
-3
-4
-4
-4
-4
-3
Investing Cash Flow
-
0
0
0
0
-
0
-
0
Financing Cash Flow
-
9
1
13
6
1
4
1
8
Change in Cash
-
1
0
9
2
-2
0
-2
4

Cingulate Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-7
-20
-17
-23
-15
-22
Operating Cash Flow
-6
-10
-15
-15
-18
-17
Investing Cash Flow
0
0
0
0
0
0
Financing Cash Flow
7
26
4
9
30
16
Change in Cash
0
15
-11
-5
12
-1

Global Institutional Holdings in Cingulate Inc

Funds
Holdings
Vanguard Group Inc
1.3%
XTX Topco Ltd
0%
Kestra Advisory Services, LLC
1.05%
XTX Topco Ltd
0.18%
Quadrature Capital Limited
0.13%

Insights on Cingulate Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CING stock has moved up by 12.7%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CING has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 47.4% return, outperforming this stock by 145.1%

About Cingulate Inc

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
OrganisationCingulate Inc
Headquarters1901 West 47th Place, Kansas City, KS, United States, 66205
IndustryBiotechnology
CEODr. Shane J. Schaffer Pharm.D.
E-voting on sharesClick here to vote

Key Management of Cingulate Inc

Name

Title

Mr. Thomas Dalton

Vice President of Investor & Public Relations

Mr. Downey Bryan Wade

Executive VP & Chief Commercial Officer

Dr. Shane J. Schaffer Pharm.D.

Co-Founder, CEO & Director

Dr. Matthew N. Brams M.D.

Co-Founder, Executive VP & Chief Medical Officer

Ms. Jennifer L. Callahan CPA

Executive VP, CFO & Secretary

Mr. Nilay D. Patel J.D.

Executive VP, Chief Legal Officer & Chief Compliance Officer

Dr. Raul R. Silva M.D.

Co-Founder, Executive VP & Chief Science Officer

FAQs

What is Cingulate Inc share price today?

Cingulate Inc share price today is $5.88 as on at the close of the market. Cingulate Inc share today touched a day high of $6.6 and a low of $5.84.

What is the 52 week high and 52 week low for Cingulate Inc share?

Cingulate Inc share touched a 52 week high of $11.89 on and a 52 week low of $3.2 on . Cingulate Inc stock price today i.e. is closed at $5.88,which is 50.55% down from its 52 week high and 83.75% up from its 52 week low.

What is Cingulate Inc's market capitalisation today?

Cingulate Inc market capitalisation is $0.00T as on .

How to invest in Cingulate Inc Stock (CING) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cingulate Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cingulate Inc Shares that will get you 0.2551 shares as per Cingulate Inc share price of $5.88 per share as on April 22, 2026 at 1:29 am IST.

What is the minimum amount required to buy Cingulate Inc Stock (CING) from India?

Indian investors can start investing in Cingulate Inc (CING) shares with as little as ₹93.505 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹935.05 in Cingulate Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Cingulate Inc share’s latest price of $5.88 as on April 22, 2026 at 1:29 am IST, you will get 1.7007 shares of Cingulate Inc. Learn more about fractional shares .